Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is downregulated by autophagy. by Jabir, Majid Sakhi et al.
Mitochondrial damage contributes to
Pseudomonas aeruginosa activation of the
inflammasome and is downregulated
by autophagy
Majid Sakhi Jabir,1,2 Lee Hopkins,3 Neil D. Ritchie,1 Ihsan Ullah,1 Hannah K. Bayes,1 Dong Li,1 Panagiotis Tourlomousis,3
Alison Lupton,4 Daniel Puleston,5 Anna Katharina Simon,5 Clare Bryant,3 and Thomas J. Evans1,*
1Institute of Immunity, Infection and Inflammation; University of Glasgow; UK; 2Biotechnology Department; Applied Science School; University of Technology; Baghdad, Iraq;
3Department of Veterinary Medicine; University of Cambridge; UK; 4Department of Pathology; Western Infirmary; Glasgow, UK; 5Human Immunology Unit; Weatherall Institute of
Molecular Medicine; University of Oxford; UK
Keywords: DNA detection, infection, mitophagy, NLR proteins, type III secretion system
Abbreviations: Three-MA, 3-methyladenine; AIM2, absent in melanoma 2; ATG, autophagy related; ATPIF1, ATPase inhibitory
factor 1; BID, BH3 interacting domain death agonist; BMDM, bone marrow-derived macrophages; BrdU, 5-bromo-2-deoxyuridine;
CASP, caspase; GFP, green fluorescent protein; IL1B, interleukin 1, b; LC3B, microtubule-associated protein 1 light chain 3 b;
LDH, lactate dehydrogenase; LPS, lipopolysaccharide; Mito-TEMPO, (2-(2, 2, 6, 6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-
oxoethyl)triphenylphosphonium chloride; MT-CO1, mitochondrially encoded cytochrome c oxidase I; mtDNA, mitochondrial
DNA; NAC, N-acetylcysteine; NAIP, NLR family apoptosis inhibitor; NGS, normal goat serum; NLR, nucleotide-binding domain,
leucine-rich repeat containing; NLRC4, NLR family, CARD domain containing 4; NLRP3, NLR family, pyrin domain containing 3;
PBS, phosphate-buffered saline; PINK1, PTEN induced putative kinase 1; Rn18s, 18S rRNA; T3SS, type III secretion system; TNF,
tumor necrosis factor; TUBB5, tubulin, b 5 class I; Vav, vav 1 oncogene.
The nucleotide-binding domain, leucine-rich repeat containing family caspase recruitment domain containing 4
(NLRC4) inflammasome can be activated by pathogenic bacteria via products translocated through the microbial type
III secretion apparatus (T3SS). Recent work has shown that activation of the NLRP3 inflammasome is downregulated by
autophagy, but the influence of autophagy on NLRC4 activation is unclear. We set out to determine how autophagy
might influence this process, using the bacterium Pseudomonas aeruginosa, which activates the NLRC4 inflammasome
via its T3SS. Infection resulted in T3SS-dependent mitochondrial damage with increased production of reactive oxygen
intermediates and release of mitochondrial DNA. Inhibiting mitochondrial reactive oxygen release or degrading
intracellular mitochondrial DNA abrogated NLRC4 inflammasome activation. Moreover, macrophages lacking
mitochondria failed to activate NLRC4 following infection. Removal of damaged mitochondria by autophagy
significantly attenuated NLRC4 inflammasome activation. Mitochondrial DNA bound specifically to NLRC4
immunoprecipitates and transfection of mitochondrial DNA directly activated the NLRC4 inflammasome; oxidation of
the DNA enhanced this effect. Manipulation of autophagy altered the degree of inflammasome activation and
inflammation in an in vivo model of P. aeruginosa infection. Our results reveal a novel mechanism contributing to
NLRC4 activation by P. aeruginosa via mitochondrial damage and release of mitochondrial DNA triggered by the
bacterial T3SS that is downregulated by autophagy.
Introduction
One of the main mediators of the innate immune response is
the cytokine IL1B (interleukin 1 b). IL1B production is tightly
regulated by a multisubunit protein complex termed the inflam-
masome.1 At its core is CASP1 (caspase 1), which on activation
will not only produce mature IL1B from pro-IL1B but also
release of active IL18/interleukin 18, a cytokine important in
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Th1 cell development.2 Understanding the mechanisms regulat-
ing inflammasome activation is thus of crucial importance in
comprehending its role in innate immune response to infection
as well as numerous inflammatory conditions.
The inflammasome based on the NLR protein NLRC4 is acti-
vated by a number of bacterial pathogens via their type III secre-
tion system.1 The activation is dependent on bacterial products,
notably flagellin3,4 and PrgJ,5,6 one of the rod proteins found in
the T3SS. These proteins in murine cells interact with the adap-
tors NAIP5 (NLR family, apoptosis inhibitorory protein 5) and
NAIP2, respectively, leading to NLRC4 inflammasome activa-
tion.6,7 T3SS needle proteins have also been described as activa-
tors of the NLRC4 inflammasome,8 via NAIP1 and human
NAIP. A separate inflammasome based on the NLR protein
NLRP3 is activated by a very different set of stimuli, including
ATP, pore-forming bacterial toxins, and a variety of particulate
matter including silica, asbestos, and alum adjuvants.9 Recent
research has attempted to identify a common mechanism of
NLRP3 activation underlying such a disparate group of stimuli.
A number of studies have highlighted the role of mitochondrial
production of reactive oxygen intermediates and release of mito-
chondrial DNA as essential in the activation of NLRP3.10-12
Autophagy thus downregulates this activation through the
removal of damaged mitochondria—mitophagy.13 Release of
DNA into the cytosol would be expected to activate the DNA
binding protein AIM2 (absent in melanoma 2), which in turn
assembles an active inflammasome. However, lipopolysaccharide
(LPS) C ATP activation of the NLRP3 inflammasome is inde-
pendent of AIM2,14 despite mitochondrial damage and release of
mitochondrial DNA into the cytoplasm. Thus, additional mech-
anisms must be operational upon LPS C ATP stimulation to
direct an NLRP3-dependent yet AIM2 independent response to
cytosolic DNA. One possible mechanism could be through intra-
cellular compartmentalization of NLRP3, which localizes to
mitochondria through binding to the adaptor mitochondrial
antiviral signaling protein.15 This might explain why release of
mitochondrial DNA can activate NLRP3 but not AIM2. This is
controversial, however, as a recent paper suggests that the only
mechanism underlying NLRP3 activation is a decrease in intra-
cellular KC ions.10
A previous study of inflammasome activation by the patho-
gen Vibrio parahaemolyticus suggested that a bacterial effector,
VopQ, inhibited NLRC4 inflammasome activation by inducing
autophagic degradation, but the mechanism was not deter-
mined.16 We have recently found in an in vivo model of Pseudo-
monas aeruginosa infection in mice that autophagy
downregulates inflammasome activation by this microbe.17 We
set out therefore to examine in more detail the influence of
autophagy on the activation of the NLRC4 inflammasome by
the T3SS of P. aeruginosa, which produces a rapid activation of
the NLRC4 inflammasome by a mechanism that is entirely
dependent on its T3SS.3,4,18,19 Infection with this bacterium
also initiates autophagy.17,20 We found that inhibition of
autophagy upregulated inflammasome activation following P.
aeruginosa infection. This was due to autophagy removing dam-
aged mitochondria that released mitochondrial DNA following
infection in a process dependent on production of reactive oxy-
gen intermediates. Released mitochondrial DNA contributed to
activation of the NLRC4 inflammasome. Manipulation of the
autophagy pathway in vivo following P. aeruginosa infection
directly altered levels of IL1B produced. These results demon-
strate a novel pathway contributing to activation of the NLRC4
inflammasome through T3SS-induced mitochondrial damage
and release of mitochondrial DNA.
Results
Autophagy inhibits inflammasome activation following
P. aeruginosa infection
P. aeruginosa infection activates the NLRC4 inflammasome
via its T3SS. We have previously demonstrated that P. aeruginosa
induces autophagy in bone marrow-derived macrophages
(BMDMs) in a toll-like receptor 4 dependent fashion.17 We set
out to examine the effect of an absence of autophagy on the acti-
vation of the NLRC4 inflammasome by P. aeruginosa using
BMDMs from mice with a targeted deletion of the essential gene
Atg7 (autophagy-related 7) in marrow precursors (vav 1 oncogene
(Vav1)-atg7¡/¡) mice.21 We assayed for the induction of autoph-
agy by measuring production of the lipidated form of microtu-
bule-associated protein 1 light chain 3B (LC3B-II), and the
appearance of LC3B puncta22 (Fig. S1A to C). As we have previ-
ously demonstrated,17 following infection of macrophages from
the Vav1-atg7¡/¡ mice there was a virtually complete inhibition
of autophagy compared to infected cells from wild-type mice
(Fig. S1A to C). We then compared inflammasome activation
following infection in macrophages from wild-type and Vav1-
atg7¡/¡mice. In the absence of autophagy, we found that inflam-
masome activation was markedly increased, as shown by
enhanced conversion of CASP1 to the active p10 form, greater
production of secreted IL1B, but no significant change in
secreted TNF (tumor necrosis factor) (Fig. 1A). Knockdown of
the essential autophagy gene Atg523 using siRNA significantly
attenuated autophagy following infection (Fig. S1D). ATG5
knockdown led to increased production of IL1B but not TNF
and enhanced inflammasome activation (Fig. 1B). In all these
experiments, cell death as assayed by lactate dehydrogenase
(LDH) release was less than 10% with the times and conditions
of infection stated (data not shown).
In a similar fashion, knockdown of Lc3b with siRNA in
BMDMs also increased production of activated CASP1 and IL1B
following infection but not TNF (Fig. 1C). We confirmed that
macrophages from Vav1-atg7¡/¡ mice lacked ATG7 (Fig. 1D)
and that there was high efficiency of knockdown of LC3B and
ATG5 by immunoblot (Fig. 1E and F). Pharmacological inhibi-
tion of autophagy with 3-methyladenine (3-MA) also increased
inflammasome activation following infection of BMDMs with the
PA103DUDT and wild-type PAO1 strains of P. aeruginosa
(Fig. S1E and F). We extended these observations to other murine
and human cells. 3-MA inhibited autophagy in the human cell
line THP-1, murine dendritic cells, and the murine macrophage
line J774A.1 and also reduced the induction of LC3B puncta
www.tandfonline.com 167Autophagy
Figure 1. Autophagy downregulates activation of the inflammasome by P. aeruginosa. (A) BMDMs from wild-type mice (Vav1-atg7C/C) or mice with a
conditional deletion of Atg7 in bone marrow-derived cells (Vav1-atg7¡/¡) were infected with PA103DUDT and autophagy quantified. Panels show immu-
noblots for indicated proteins in cells infected as shown. Graphs show secretion of active IL1B and TNF from basal and infected BMDMs as shown. Col-
umns are means of 3 independent determinations; error bars are SEM. * indicates a significant difference between the levels in BMDMs from WT or
Vav1-atg7¡/¡ mice, P < 0.05. n.s., not significant. (B) As (A), but in cells depleted of Atg5 by siRNA knockdown as shown. (C) As (A) but in cells depleted
of Lc3b by siRNA knockdown as shown and infected as indicated. ** indicates a significant difference between the levels in BMDMs from Lc3b siRNA-
treated cells and control, P< 0.01. ((D)to F) Immunoblots of key proteins (including the ATG12&z.vrecto;ATG5 conjugate) of (A) to (C) depleted by knock-
out or knockdown as shown, with TUBB5/b-tubulin as control. C is control. D, BMDMs from WT or Vav1-atg7 knockout animals as shown probed for
ATG7. (E) and (F), BMDMs treated with siRNA or control siRNA to Atg5 (E) and Lc3b (F).
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(data not shown). In all these different cells this increased the lev-
els of secreted IL1B (Fig. S2). These data show that in the absence
of autophagy, there is an increase in the activation of the NLRC4
inflammasome following P. aeruginosa infection.
Mitochondrial reactive oxygen activates the inflammasome
following P. aeruginosa infection
We hypothesized that the increase in inflammasome activation
in P. aeruginosa-infected cells after inhibition of autophagy was due
Figure 2. Infected BMDMs undergo mitophagy. (A) Representative confocal images of BMDMs infected with PA103DUDT (MOI 25 for 4 h) and stained for
LC3B (green), and mitochondrial ATPIF1 (Mito, red); nuclei are stained blue with DAPI. Coloc shows areas of colocalization of the mitochondrial and LC3B
staining in gray. Overlay shows the merged LC3B and mitochondrial signals; colocalizing areas shown as yellow. Scale bar D 5 mm. Repeated 3 times.
((B)to E) Electron micrographs of autophagosomes of untreated BMDM (B) or infected with PA103DUDT(MOI 25) for 4 h (C) to (E). Arrowhead indicates
autophagosome with enclosing double membrane, M indicate mitochondria. Scale bar is 500 nm. Representative image from > 10 infected cells. (F)
Immunoblot of BMDMs infected at a MOI of 25 with PA103DUDT for the indicated times probed for PINK1. Full-length and cleaved PINK1 are labeled.
The blot was reprobed for TUBB5 as a loading control. (G) As (F) but with infections and treatments as shown and is representative of 2 independent
experiments.
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to an increase in release of reactive oxygen intermediates from defec-
tive mitochondria that failed to be removed by mitophagy. To con-
firm that mitochondria were being removed by mitophagy
following infection, we performed localization studies using immu-
nofluorescent microscopy (Fig. 2A). Following infection of
BMDMs with PA103DUDT, we found extensive colocalization of
mitochondria with the LC3B protein that localizes on autophagic
vacuoles. We analyzed cells at much higher resolution using trans-
mission electron microscopy to look for mitochondria within the
characteristic double-membrane autophagosomes. In uninfected,
mitochondria were easily visualized but we did not detect any
within autophagosomes (Fig. 2B). Following infection with
PA103DUDT, mitochondria were readily visible within autopha-
gosomes with a characteristic double-membrane structure
(Fig. 2C). In this panel, the cristae of the mitochondria are visible.
In other images, we were able to identify double-membrane struc-
tures within autophagosomes that are consistent with mitochondria
(Fig. 2D and E), although cristae were not readily visible, consistent
with the mitochondrial damage described following mitophagy.24
Electron microscopy images are difficult to quantify, thus to assay
the level of mitophagy accurately we used a biochemical method.
The delivery of damaged mitochondria to autophagic vacuoles is
controlled by the mitochondrial protein PINK1 (PTEN induced
putative kinase 1).25 This normally undergoes proteolytic process-
ing by healthymitochondria, but following damage and depolariza-
tion, this processing is abrogated and full-length PINK1
accumulates on the surface of mitochondria. Full-length PINK1
then recruits parkin to the mitochondrial surface and initiates
mitophagy. Western blotting of BMDM lysates following infection
with PA103DUDT showed an accumulation of full length com-
pared to cleaved PINK1 (Fig. 2F). This was almost completely
reversed by (2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-
oxoethyl)triphenylphosphonium chloride (Mito-TEMPO), a spe-
cific inhibitor of mitochondrial reactive oxygen production26
(Fig. 2G). PA103 lacking a functional T3SS that does not activate
the inflammasome, PA103pcrV¡, showed levels of cleaved PINK1
that were increased compared to cells infected with the T3SS intact
PA103DUDT strain (Fig. 2G). These data show that mitochondria
are damaged by the T3SS system in P. aeruginosa infection leading
to inhibition of PINK1 cleavage that then initiates mitophagy.
Next, we examined the production of reactive oxygen by
mitochondria following infection with P. aeruginosa and the
effect of this on inflammasome activation. Following infection
with PA103DUDT there was a marked increase in mitochondrial
reactive oxygen production (Fig. 3A). However, following infec-
tion with the PA103pcrV¡ mutant that does not have a func-
tional T3SS and does not produce inflammasome activation,19
mitochondrial reactive oxygen was not increased (Fig. 3A). To
test the dependence of inflammasome activation following P. aer-
uginosa infection on production of mitochondrial reactive oxygen
production, we used the general reactive oxygen inhibitor N-ace-
tylcysteine (NAC) as well as Mito-TEMPO. Following infection,
these inhibitors produced a dose-dependent reduction in CASP1
activation and production of active IL1B (Fig. 3B), but with no
effect on secreted TNF. Both inhibitors produced the expected
reduction in mitochondrial production of reactive oxygen
(Fig. 3C). PA103 lacks functional flagella, thus it activates
NLRC4 via NAIP2 rather than NAIP5/6.6,27 To determine if
reactive oxygen production was important in infections with flag-
ellated P. aeruginosa that can activate NLRC4 via NAIP5/6, we
utilized the wild-type strain PAO1. Infection with PAO1 pro-
duced an increased output of mitochondrial reactive oxygen that
was inhibited by Mito-TEMPO and NAC (Fig. 3D). Infection
of BMDMs with this strain activated the inflammasome with
production of the p10 CASP1 fragment and secreted IL1B: Both
NAC and Mito-TEMPO inhibited this activation (Fig. 3E).
Thus, P. aeruginosa signaling via either NAIP2 or NAIP5/6 pro-
duces mitochondrial reactive oxygen intermediates that are
important in NLRC4 inflammasome activation.
Next, we tested the effect of inhibiting autophagy on the pro-
duction of mitochondrial reactive oxygen intermediates following
infection of BMDMs with P. aeruginosa PA103DUDT. In
BMDMs from mice lacking the essential autophagy gene Atg7 in
bone-marrow cells (Vav1-atg7¡/¡) there was an increase in the
amount of mitochondrial reactive oxygen produced following
infection compared to control wild-type animals (Fig. 3F). Pro-
duction of mitochondrial reactive oxygen intermediates following
infection was further increased when autophagy was inhibited
with 3-MA (Fig. S3A). We also attenuated autophagy by knock-
down of the essential autophagy proteins LC3B and ATG5 using
siRNA. Using both these approaches, we observed a marked
increase in the production of mitochondrial reactive oxygen
intermediates following infection (Fig. S3B and S3C). Taken
together, these data show that autophagy reduced the levels of
mitochondrial reactive oxygen produced following infection of
BMDMs with P. aeruginosa.
We then determined whether increased inflammasome activa-
tion following inhibition of autophagy in infected cells was due
to increased mitochondrial reactive oxygen production. To pro-
vide definitive evidence for the role of autophagy in downregulat-
ing inflammasome activation following infection, we used
BMDMs from Vav1-atg7¡/¡ mice. In infected cells from Vav1-
atg7¡/¡ mice, Mito-TEMPO reduced IL1B but not TNF pro-
duction and inhibited the production of activated CASP1
(Fig. 3G): Mito-TEMPO also inhibited the increase in IL1B
production and generation of activated CASP1 that was seen
when autophagy was prevented by knockdown of Atg5 with
siRNA (Fig. S3D).
We hypothesized that the mitochondrial damage following P.
aeruginosa infection might also result in release of mitochondrial
DNA. First, we assayed for cytoplasmicmitochondrial DNA release
following infection of BMDMs. The copy number of cytoplasmic
nuclear DNA encoding 18S rRNA (Rn18s) was not altered by infec-
tion (data not shown). Following infection with PA103DUDT
there was a marked increase in the relative amount of mitochondrial
to nuclear cytoplasmic DNA (Fig. 4A). This was further increased
by inhibiting autophagy with 3-MA or by knockdown of Lc3b with
siRNA (Fig. 4A and B). Inhibiting mitochondrial reactive oxygen
production with Mito-TEMPO significantly inhibited mitochon-
drial DNA release (Fig. 4A and B).
Further, to establish the importance of mitochondria in the
activation of the NLRC4 inflammasome by P. aeruginosa, we
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grew J774A.1 murine macrophages in ethidium bromide to gen-
erate cells that lack mitochondria (rJ774A.1).28 We confirmed
that these cells had lost mitochondria by measuring cellular mito-
chondrial DNA content by quantitative PCR, western blotting
cell lysates for the mito-
chondrial protein ATPase
inhibitory factor 1
(ATPIF1), and flow
cytometry of cells stained
with the mitochondrial
specific dye MitoTracker
Green (Fig. 4C and D). Infection of the rJ774A.1 cells with
PA103DUDT gave no increase in mitochondrial reactive oxygen
production (Fig. 4E). Moreover, when infected with
PA103DUDT the rJ774A.1 cells lacking mitochondria failed to
Figure 3. Production of
mitochondrial reactive oxy-
gen following P. aeruginosa
infection leads to inflamma-
some activation. (A) Flow
cytometry of untreated
BMDMs (basal) or infected as
indicated and stained with
MitoSOX Red. (B) Immuno-
blot as in Figure 1A of
BMDMs pretreated for 1 h
with Mito-TEMPO (250, or
500 mM) or NAC (10 or
25 mM) then infected with
PA103DUDT (MOI 25) for
4 h. The lower panels show
ELISA of IL1B and TNF secre-
tion as in Figure 1A. ** and
*** indicate significant differ-
ences between the levels in
the presence and absence of
the Mito-TEMPO and NAC, P
< 0.01 and < 0.001 respec-
tively. (C) Flow cytometry of
uninfected BMDM (basal) or
pretreated for 1 h with Mito-
TEMPO (500 mM) or NAC
(25 mM) then infected with
PA103DUDT (MOI 25) for 4 h
and stained with MitoSOX
Red. (D) as in (C), but in cells
infected with PAO1. (E) As
(B) but in cells infected with
PA01 as shown. (F) Flow
cytometry of cells from
Vav1-atg7¡/¡ or Vav1-atg7C/
C mice left uninfected
(basal) or infected with
PA103DUDT (MOI 25) for 4 h
and stained with MitoSOX
Red. (G) Immunoblot and
ELISA as in (B) from Vav1-
atg7C/C and Vav1-atg7¡/¡
BMDMs treated as shown.
*** indicates significant dif-
ferences from the levels pro-
duced from infected Vav1-
atg7¡/¡ cells, P < 0.001. n.s.
not significant. All data are
representative of 3 indepen-
dent experiments.
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Figure 4. For figure legend, see page 173.
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activate CASP1 and produced significantly less IL1B but similar
amounts of TNF (Fig. 4F). Autophagy, as assayed by the forma-
tion of LC3B-II (Fig. 4F) and appearance of LC3B puncta (data
not shown), was maintained in rJ774A.1 cells compared to
J774A.1, showing that loss of mitochondria had not inhibited
this energy-requiring process. Thus, these data also support the
conclusion that mitochondria play an important role in the acti-
vation of the NLRC4 inflammasome by P. aeruginosa.
Mitochondrial DNA contributes to activation of the NLRC4
inflammasome
Next, we explored the role, if any, of cytoplasmic mitochon-
drial DNA in activating the NLRC4 inflammasome following P.
aeruginosa infection. We transfected BMDMs with DNASE1, or
with a control protein LDH or heat-inactivated DNASE1. LDH
or heat-inactivated DNASE1 did not affect the production of
activated CASP1 or production of IL1B following infection
(Fig. 5A). However, active DNASE1 prevented CASP1 activa-
tion and significantly reduced the production of mature IL1B fol-
lowing infection without affecting production of TNF (Fig. 5A).
DNASE1 treatment reduced the presence of cytosolic mitochon-
drial DNA as expected (Fig. 5A). Transfection of active
DNASE1 also reduced the inflammasome activation produced
by infection of BMDMs with wild-type PAO1 P. aeruginosa,
without affecting TNF (Fig. S4).
The DNA sensor AIM2 might be responsible for these
observed effects, as it contributes to the activation of the inflam-
masome by a number of pathogens. Although NLRP3 has been
suggested to bind and be activated by DNA, this protein does
not contribute to activation of the inflammasome following P.
aeruginosa infection.18,19 This is considered further in the discus-
sion. To examine the contribution of AIM2 to activation of the
inflammasome by P. aeruginosa, we measured secreted IL1B fol-
lowing infection in BMDMs from WT and Aim2 knockout
mice.14 We found that the levels of secreted IL1B were signifi-
cantly reduced from the infected Aim2 knockout BMDMs com-
pared to those derived from WT animals (Fig. 5B). Thus, AIM2
contributes to inflammasome activation in P. aeruginosa infec-
tion. We also examined the effect of transfected mitochondrial
DNA on IL1B production in infected BMDMs from mice with
a knockout of the Aim2 gene (aim2‑/¡). Even in the absence of
AIM2, transfected mitochondrial DNA boosted IL1B produc-
tion in infected cells; oxidized DNA was more effective and TNF
levels were unchanged (Fig. 5B). Thus, although AIM2
contributes to activation of the inflammasome following infec-
tion with P. aeruginosa, this suggests that an additional DNA sen-
sor or sensors also is present in these cells that can contribute to
inflammasome activation.
We speculated that NLRC4 might itself be activated by
released mitochondrial DNA. Therefore, we repeated these
experiments using BMDMs from mice with a knockout of the
Nlrc4 gene (nlrc4¡/¡). LPS primed cells were then transfected
with mitochondrial DNA and inflammasome activation deter-
mined. Compared to wild-type BMDMs (Nlrc4C/C), transfec-
tion of mitochondrial DNA into Nlrc4 knockout cells produced
significantly reduced amounts of IL1B and activated CASP1
(Fig. 5C). There was still some residual response to mitochon-
drial DNA in the nlrc4¡/¡ cells as would be expected from
remaining AIM2 and NLRP3, but it was substantially and signif-
icantly reduced. Thus, NLRC4 can, independently of NLRP3
and AIM2, mediate activation of the inflammasome in response
to transfected mitochondrial DNA.
NLRC4 interacts with and is activated by mitochondrial
DNA
We hypothesized that the activation of the NLRC4
inflammasome by mitochondrial DNA was mediated by
binding to the NLRC4 protein. To test this, we grew cells in
5-bromo-2-deoxyuridine (BrdU) and prepared cell lysates
before and after infection. NLRC4 was immunoprecipitated
from the lysates and bound DNA in the immunoprecipitates
detected by probing slot blots of the eluates with antibody to
BrdU (Fig. 6A). We added 3-MA to some of the cells prior
to lysis to block autophagy and thus enhance the release of
mitochondrial DNA. In lysates prepared from uninfected
cells, no DNA was detected in the NLRC4 immunoprecipi-
tates, even in the presence of 3-MA (Fig. 6A). Following
infection, NLRC4, but not control, immunoprecipitates con-
tained DNA; the amount was further increased in the pres-
ence of 3-MA (Fig. 6A). We repeated this experiment, but
probed the slot blot with an antibody to 8-OH deoxyguano-
sine, a modified deoxynuceloside found commonly in oxi-
dized DNA.29 NLRC4, but not control, immunoprecipitates
contained material reacting with this antibody (Fig. 6B). The
findings were further corroborated by probing the immuno-
precipitates with a generic DNA antibody, which gave the
same result (Fig. 6C). Thus, following infection with P. aeru-
ginosa, NLRC4 has a direct or indirect interaction with
Figure 4. (See previous page.)Mitochondrial DNA release following infection and requirement for mitochondria for inflammasome activation by P. aer-
uginosa. (A) and (B), qPCR analysis of cytosolic mitochondrial DNA (mtDNA) relative to nuclear DNA in macrophages pretreated (A) with Mito-TEMPO
(500 mM) or 3-MA (10 mM) or control or Lc3b siRNA (B) and infected with PA103DUDT (MOI 25) for 4 h or uninfected (Basal) as shown. Columns show
means of 3 independent determinations; error bars are SEM. (C) Mitochondrial content of J774A.1 cells exposed to ethidium bromide (EtBr) at the indi-
cated concentration (ng/ml) measured by qPCR (normalized to untreated cells; upper panel) and immunoblot for the mitochondrial protein ATPIF1
(lower panel) at low and high exposure time; TUBB5 is shown as a loading control. (D) Mitochondrial content of control or ethidium bromide-treated
J774A.1 cells (rJ774A.1) assayed by flow cytometry of MitoTracker Green stained cells. (E) Flow cytometry of J774A.1 and rJ774A.1 cells left uninfected
(Basal) or infected with PA103DUDT (MOI 25) for 4 h and stained with MitoSOX Red. (F) J774A.1 cells grown in the absence or presence of 500 ng/ml
ethidium bromide (EtBr) were left untreated (basal) or infected with PA103DUDT (MOI 25) for 4 h and analyzed as described in Figure 1A. *** indicates
significant differences between the levels in the presence and absence of the EtBr (500 ng/ml), P < 0.001. All data are representative of results from 2 or
3 independent experiments.
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DNA, including DNA that has undergone oxidation. To
demonstrate that this DNA is mitochondrial in origin, we
performed NLRC4 immunoprecipitation from both infected
J774A.1 and rJ774A.1 that lack mitochondria. In lysates
from infected cells lacking mitochondria, immunoprecipitates
of NLRC4 did not contain DNA (Fig. 6D).
Next, we set out to determine if the interaction between
NLRC4 and mitochondrial DNA was important in initiating
inflammasome activation. To determine if mitochondrial DNA
could directly activate NLRC4, we tested the effect of mitochon-
drial DNA on CASP1 activation in a reconstituted cell-based
assay. Using a variety of transfection reagents, we detected ‘spots’
of activated CASP1 in cells following transfection of mitochon-
drial DNA, but not in control cells transfected without DNA
(Fig. 6E). Thus, mitochondrial DNA alone is sufficient in this
assay to result in NLRC4 inflammasome activation.
Manipulation of autophagy alters inflammasome activation
in vivo following P. aeruginosa infection
We have previously found that autophagy appears to reduce
NLRC4 activation following P. aeruginosa infection in vivo.17
We hypothesized that by drug manipulation of autophagy we
could alter inflammasome activation in vivo. First, we tested the
effect of adding the known inducers of autophagy, rapamycin
and resveratrol, to P. aeruginosa infected BMDMs as well as the
macrophage lines J774A.1 and THP-1. We found that these
agents augmented the degree of autophagy observed during infec-
tion (Fig. S5A to E and Fig. 7A). In all cell lines studied, the
addition of rapamycin significantly reduced the amount of IL1B
produced during infection (Fig. 7A). Neither rapamycin nor 3-
MA had any significant effect on the growth of P. aeruginosa in
culture broth (data not shown). We also increased autophagy by
transfecting BMDMs with an expression plasmid for murine
Atg5. (Fig. S5C to F). This treatment attenuated production of
IL1B and release of cytosolic mitochondrial DNA following
infection (Fig. 7B), as well as inhibiting production of mitochon-
drial reactive oxygen (Fig. 7C). We also confirmed that infection
with P. aeruginosa truly increased flux through the autophagy
pathway by following the fate of transfected tandem green fluo-
rescent protein (GFP)-mCherry-LC3B.30 The GFP from this
fusion protein loses its fluorescence in the acidic environment
induced in autophagosomes when they fuse with lysosomes while
the signal from the acid-resistant mCherry remains intact. As
shown in Fig. S6A, at 2 h following infection or treatment with
autophagy inducers, virtually all puncta are positive for both the
GFP and mCherry signal. At 4 h after infection, there is a
dramatic reduction in the number of green puncta, while the red
puncta are still clearly visible. At 6 h after infection, virtually no
green puncta are visible, while red puncta are beginning to coa-
lesce into larger vesicles. Quantification of the numbers of green
puncta at various times after treatment or infection showed that
these changes were statistically significant, confirming that infec-
tion or treatment with rapamycin or resveratrol increased flux
through the autophagy pathway.
Next, we tested the effect of altering autophagy in an in vivo
model of P. aeruginosa infection in mice. Animals were infected
with the microbe intraperitoneally and the effects of augmenting
autophagy with rapamycin and inhibiting autophagy with 3-MA
studied. These treatments boosted and inhibited respectively the
degree of autophagy in cells recovered from the peritoneal cavity,
as assayed by levels of LC3B-II and LC3B puncta per cell
(Fig. 7D). We found that rapamycin treatment significantly
reduced the amount of IL1B recovered from the peritoneal cavity
and blood after infection, but had no effect on levels of TNF
(Fig. 7E). Inhibiting autophagy with 3-MA significantly
enhanced IL1B levels, with no effect on TNF (Fig. 7E). As an
indicator of disruption to the peritoneal barrier, we measured
protein concentration in peritoneal fluid recovered after infec-
tion. Rapamycin significantly reduced the protein concentration
while 3-MA enhanced it (Fig. 7F). We also measured the num-
bers of viable bacteria recovered from the peritoneal cavity fol-
lowing infection (Fig. 7G). This showed that rapamycin reduced
the numbers of bacteria while 3-MA increased these numbers.
Thus, increasing the degree of autophagy with rapamycin reduces
the amount of inflammasome activation and resulting inflamma-
tory response following infection in vivo. Inhibiting autophagy
with 3-MA has the opposite effect. However, increasing the
degree of autophagy with rapamycin results in lower numbers of
bacteria remaining after infection; again inhibition of autophagy
with 3-MA had the opposite effect.
Discussion
The results here present the novel finding that autophagy reg-
ulates NLRC4 activation following P. aeruginosa infection by
selective removal of damaged mitochondria—mitophagy. More-
over, we have shown that mitochondrial reactive oxygen species
and release of mitochondrial DNA subsequent to infection with
P. aeruginosa are important in NLRC4 activation. This estab-
lishes a novel pathway of NLRC4 activation dependent on mito-
chondrial sensing of infection that is regulated by the autophagy
pathway. We show using an in vivo peritoneal infection model
Figure 5. (See previous page.) Mitochondrial DNA activates the NLRC4 inflammasome independently of Aim2. (A) BMDMs were transfected with 3 mg
DNASE1, lactate dehydrogenase (LDH), or heat-inactivated (HI) DNASE1 as shown and then infected with PA103DUDT (MOI 25) for 4 h. The panels show
immunoblot of the indicated proteins and TUBB5 as a loading control as in Figure 1A, levels of IL1B and TNF as in Figure 1A and qPCR analysis of cyto-
solic mtDNA as in Figure 4A. *** indicates significant difference from HI DNASE1, P <0 .001. (B) ELISA of IL1B and TNF secretion from BMDMs of Aim2C/C
and aim2¡/¡mice transfected for 6 h with mtDNA, oxidized mtDNA, or DNA predigested by DNASE1 as shown and then infected with PA103DUDT (MOI
25) for 4 h as shown. Columns are means of triplicate independent determinations; error bars are SEM. *,** and *** indicate significant differences at a
level of P < 0.05, 0.01 or 0.001 respectively for the indicated comparison or from the result with oxidized DNA C infection. (C) As (A) but in LPS primed
Nlrc4C/C and nlrc4¡/¡ BMDMs transfected with mtDNA, or oxidized mtDNA as shown. Levels of significant differences are as in (B).
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with P. aeruginosa that
manipulation of the auto-
phagic pathway with rapa-
mycin and 3-MA can alter
the degree of activation of
the inflammasome and
subsequent inflammation.
This reinforces the physiological relevance of the mechanisms we
have described in this work. Additionally, it suggests that manip-
ulation of autophagy could be exploited therapeutically to mod-
ify the IL1B response following infection. Clearly, IL1B plays an
important role in host defense, but excess production of inflam-
matory mediators is deleterious as found in sepsis and septic
shock. Downregulating inflammasome activation by promoting
autophagy in sepsis might therefore be a useful therapeutic strat-
egy. Autophagy also has a role in clearance of P. aeruginosa; in
our model of infection, augmenting or inhibiting autophagy
decreased or increased respectively the numbers of bacteria recov-
ered from the peritoneal cavity (Fig. 7G).
The mechanism by which P. aeruginosa produces mitochon-
drial damage is unclear, but it is dependent on the bacterial
Figure 6. Mitochondrial
DNA is present in NLRC4
immunoprecipitates and
activates a reconstituted
NLRC4 inflammasome. (A)
BMDMs were grown in
BrdU and infected as
shown before lysates were
immunoprecipitated with
anti-NLRC4 or control rab-
bit serum as indicated.
Bound material was slot-
blotted to nitrocellulose
and then blotted with anti-
BrdU. The lower panel
shows separate immuno-
blot of eluted material
from NLRC4 immunopreci-
pitates blotted for NLRC4.
(B) As in (A), but reprobed
with antibody to 8OHdG.
(C) As (A), but blot probed
with generic anti-DNA anti-
body. (D) Immunoblot of
immunoprecipitates as set
out in (A) but in either con-
trol J774A.1 cells or in
rJ774A.1 cells lacking mito-
chondria. (E) HEK cells
transfected with NLRC4
and NAIP were transfected
with and without mito-
chondrial DNA and active
CASP1 localized by immu-
nofluorescent imaging
using FLICACasp1. Panels
show representative
images of cells stained with
FLICACasp1 (green) and
nuclei stained with DAPI
(blue) using the indicated
transfection reagents.
Arrows show spots of
active CASP1 formation.
Experiments were all
repeated 2 or 3 times.
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Figure 7. Manipulating in vitro
and in vivo levels of autophagy
modulates inflammasome acti-
vation following P. aeruginosa
infection. (A) The panels show
representative protein gel blots
of LC3B isoforms and TUBB5 as
a loading control following
infection and rapamycin
(50 mg/ml) (Rap) or resveratrol
(50 mg/ml) (Res) treatment as
indicated. Graphs are means
(with SEM as error bars) of IL1B
secretion in the same experi-
ments. *** indicates significant
difference between the levels in
the presence and absence of
rapamycin or resveratrol during
infection, P < 0.001. (B) Levels
of IL1B (upper panel) and cyto-
solic mitochondrial DNA (lower
panel) in cells transfected with
expression plasmid for murine
Atg5 (pUNO1-mAtg5) or control
plasmid (pUC19) infected as
shown. (C) Flow cytometry of
BMDMs transfected with plas-
mids as indicted and infected
as shown and stained for mito-
chondrial reactive oxygen with
mitososx. (D to G), results from
intraperitoneal infection of
female C57BL/6 mice with
PA103DUDT treated with rapa-
mycin (R), or 3-methyl adenine
as indicated. (D) Levels of LC3B-
I and -II in recovered peritoneal
cells following infections and
treatments as shown; lower
panel shows mean (§ SEM)
numbers of LC3B containing
puncta per cell as described in
Fig. S1B. (E) Levels (n D 3) of
IL1B and TNF (error bars are
SEM) in the blood (left panels)
and peritoneal washings (right
panels) before and 6 h after
infection with the indicated
treatments. * and ** and ***
indicate significant differences
from the levels in infected ani-
mals with no pretreatment, P <
0.05, 0.01 and 0.001 respec-
tively. (F) Protein concentration
in peritoneal fluid following
infection and treatments shown.
(G) Bacterial colony counts per
ml of recovered fluid from the
peritoneal cavity with the treat-
ments as shown. Columns are
means of triplicate determina-
tions, error bars SEM. (D to G)
Representative data from 2
independent in vivo experi-
ments. Other experiments were
repeated 2 or 3 times.
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T3SS. Flagellin31 and components of the T3SS rod and needle
complex have been reported to activate the NLRC4 inflamma-
some, utilizing proteins of the NAIP family as adaptors.5,6,27
How and at what level does mitochondrial damage interact with
these NAIP-dependent effects? One approach would be to mea-
sure mitochondrial reactive oxygen output and release of mito-
chondrial DNA in BMDMs from mice with selective knockout
of NAIP family members. However, we have recently found that
there is a reciprocal effect of inflammasome activation on the pro-
cess of autophagy, such that CASP1 activation leads to proteo-
lytic processing of the signaling intermediate TRIF and hence
downregulates autophagy.17 Thus, preventing NLRC4 activation
by removing the NAIP adaptors will prevent CASP1 activation
and lead to enhanced autophagy. This will lead to a reduction in
mitochondrial reactive oxygen production and release of mito-
chondrial DNA, but would not imply that the NAIP protein
interactions with bacterial products were directly responsible for
this effect. We suggest that this is the mechanism that accounts
for the apparent dependence of mitochondrial damage on
NLRP3, as reported by Nakahira et al.12
Initiation of inflammasome activation and pyroptosis has
many similarities to apoptosis, in which mitochondria play a key
role. For example, the Fas apoptotic pathway can result in cleav-
age of the protein B cell leukemia/lymphoma 2 homology
domain 3 interacting domain death agonist (BID) to a form that
moves from the cytoplasm to mitochondria where it initiates
damage and release of CYCS/cytochrome c, amplifying the apo-
ptotic signal.32 We speculate that these bacterial interactions
with NAIP proteins are upstream of a subsequent initiation of
mitochondrial damage and release of mitochondrial DNA.
Translocation of the NAIP proteins to mitochondria after activa-
tion by flagellin or T3SS rod proteins would be a possible mecha-
nism to account for T3SS dependent mitochondrial damage, in
much the same way as the mitochondrial localization of BID
leads to apoptosis.
Several groups have shown the importance of mitochondrial
damage and sensing of released mitochondrial DNA in NLRP3
inflammasome activation;11,12 removal of damaged mitochondria
by selective autophagy (mitophagy) inhibits this activation. Thus,
the question remains as to how specific NLRP3 or NLRC4
inflammasome activation can be achieved through an identical
signal. Moreover, despite the presence of cytoplasmic mitochon-
drial DNA following LPS C ATP stimulation that is able to bind
and activate the NLRP3 inflammasome, this apparently does not
result in activation of the DNA-sensing AIM2 inflammasome,
which plays no part in this process.14 Likewise, NLRP3 plays no
part in the activation of the inflammasome by P. aeruginosa,18
yet we show here that infection by this microbe results in accu-
mulation of cytoplasmic mitochondrial DNA that in LPS C
ATP treatment of cells has been shown to activate the NLRP3
inflammasome. We propose that additional proteins must be
involved in triggering either a NLRC4 or NLRP3 response.
These might be NAIP family members that in the context of
binding to flagellin or T3SS rod/needle proteins direct a NLRC4
response over NLRP3 activation. As the original description of
the inflammasome makes clear, an activating signal is required to
bring together an inflammasome complex.33 Thus, the presence
of particular activated binding partners, such as NAIPs, may lead
to assembly of the NLRC4 inflammasome, while different pro-
tein interactions may produce a NLRP3 inflammasome. For
example, the guanylate binding protein 5 is important for assem-
bly of the NLRP3 inflammasome for some, but not all, triggering
stimuli.34 Indeed, different inflammasomes may assemble at dif-
ferent times during a triggering event such as an infection. A role
for mitochondrial damage and sensing of mitochondrial DNA
may therefore be a common factor that is required for the final
activation of the assembled inflammasome. Certainly NLRC4
can respond directly to the presence of cytoplasmic DNA as the
data in Fig. 6E demonstrate. The contribution of this to the over-
all activation of the inflammasome in P. aeruginosa infection is
not clear. Transfected DNASE1 reduced inflammasome activa-
tion following infection almost completely (Fig. 5A). This sug-
gests that cytoplasmic DNA is required as a factor in
inflammasome activation in P. aeruginosa infection. Activation of
AIM2 by DNA will also contribute to any effect of NLRC4 acti-
vation by DNA.
P. aeruginosa that lack a functional T3SS can activate the
NLRP3 inflammasome by a mechanism that requires a TRIF-
dependent activation of CASP11.35,36 This is a slower process
than activation via the T3SS as it requires transcriptional activa-
tion of CASP11, which typically takes some hours. All the work
described here was with P. aeruginosa that has an active T3SS
which produces rapid inflammasome activation that is indepen-
dent of CASP11 and NLRP3 and is abolished in the absence of
NLRC4.19,35 Thus, the involvement of mitochondria in the acti-
vation of the inflammasome that we describe here is quite inde-
pendent of CASP11 and NLRP3 involvement.
We show here that immunoprecipitated NLRC4 contains
bound mitochondrial DNA (Fig. 6). Similar results have been
found for NLRP3. We do not know whether DNA is binding
directly to the NLR proteins or if it binds to an associated pro-
tein. Direct binding to these different NLRs might suggest a role
for the common central NOD domain of these proteins as DNA
binding elements; equally, other interacting proteins may be
involved. Further experiments to define the exact element that
interacts with DNA are required. In conclusion, the work
described here establishes a novel pathway by which infection
activates the NLRC4 inflammasome, by inducing mitochondrial
damage and release of mitochondrial DNA. This pathway is sim-
ilar to that described for the activation of the NLRP3 inflamma-
some by LPS and ATP. Further work will be required to
establish how each pathway operates independently. This study
serves to underscore the importance of mitochondria in initiating
an inflammatory response through activation of the inflamma-
some, and how control of mitochondrial quality through autoph-
agy is central in limiting this response.
Ethics Statement
All animal experiments were performed under project License
PPL60/4361 granted and approved by the UK Government
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Home Office, according to the Animals (Scientific Procedures)
Act 1986 Amendment Regulations with regard to Directive
2010/63/EU of the European Parliament and of the Council on
the protection of animals used for scientific purposes. The grant-
ing of such a project license was approved locally by the Univer-
sity of Glasgow Biological Services Ethical Review Committee
followed by approval of the application for animal work by the
UK Home Office who granted and approved the project license
allowing the work to proceed. This is the legal requirement for
all animal work within the UK and ensures all animal work is
performed according to the principles of the Weatherall Report
with due consideration of replacing, refining and reducing ani-
mal experimentation wherever possible.
Materials and Methods
Reagents
The following regents were used: Mito-TEMPO (Enzo Life-
science, ALX-430–150-M005), N-acetylcysteine (Sigma,
A7250), ethidium bromide (Sigma, 1510), LDH (Sigma,
L2500), rapamycin (Enzo lifesciences, BML-A2750025),
DNASE1/DNAse-I (Sigma, D5025), resveratrol (Invivogen,
tlr1-resv).
Animals
C57/BL6 mice were obtained from Harlan UK. The follow-
ing genetically modified mouse strains were used, all on the C57/
BL6 background: aim2¡/¡, nlrc4¡/¡ both kindly provided by K.
Fitzgerald (University of Massachusetts) and Vav1-atg7¡/¡ 37
which is a conditional deletion of Atg7 in hematopoetic cells gen-
erated in the laboratory of AKS.
Cells
Primary bone-marrow macrophages were isolated as described
from C57/BL6 mice.38 Cells were cultured in RPMI 1640
(Sigma, R8758) supplemented with 10% heat inactivated fetal
calf serum (Invitrogen, 15561020), streptomycin 100 IU/ml,
penicillin 100 IU/ml (Sigma, P0781), L-glutamine 2 mM (Invi-
trogen, 25030) and 25 mM HEPES, pH 7.3. Macrophages were
selected by addition of colony stimulating factor 1 (macrophage)
(PeproTech, 315–02) 10 ng/ml or by using the supernatant frac-
tion of L929 cells at a final concentration of 30%. Cells were
allowed to grow for between 6 to 9 d before use. Under these
conditions, the resultant cell population was > 95% macro-
phages as judged by staining with the macrophage marker EMR1
(EGF-like module containing, mucin-like, hormone receptor-
like sequence 1; F4/80). Dendritic cells were produced in a simi-
lar fashion but using growth in CSF2 (colony stimulating factor
2 [granulocyte-macrophage]; PeproTech, 315–03).
J774A.1 was from the European Collection of Cell Cultures.
The human macrophage cell line THP-1 (gift of Dr. Damo Xu,
University of Glasgow) was grown in RPMI 1640 medium sup-
plemented as above.
Bacteria
P. aeruginosa PA103DUDT and PA103pcrV¡ were kindly
provided by Dara Frank, Medical College of Wisconsin. Bacterial
strains were cultured in LB broth to mid-log phase (OD 0.4 to
0.6) immediately prior to use. Cells were washed twice in sterile
phosphate-buffered saline (PBS; Sigma, D6682) and used to
infect cells at the indicated MOI.
Immunoblot analysis
The following antibodies were used: monoclonal anti-TUBB5
(Sigma, T8328); anti-CASP1/caspase 1 p10 (Santa Cruz Bio-
technology, sc-514), anti-8-OHdG (Santa Cruz Biotechnology,
sc-66036); anti-IL1B (Abcam, ab13810); anti-LC3B (Novus
Biological, NB100–2220), anti-NLRC4 (Novus Biological,
NBP1–78979ss), anti-PINK1 (Novus Biological, BC100–494);
anti-BrdU (Sigma, Bu33); anti-dsDNA (abcam, 27156); anti-
rabbit IgG IP beads (eBioscience, 00–880025), anti-ATG7 (Cell
Signaling Technology, 2631s); anti-ATG5 (Novus Biological,
NB110–53818ss). Bound antibody was visualized using anti-rab-
bit (Cell Signaling Technology, 7074s) or anti-mouse (Cell Sig-
naling Technology, 7076) horseradish peroxidase-coupled
immunoglobulin and chemiluminescence ECL kit (GE health-
care, RPN2209).
Confocal and immunofluorescence microscopy
For immunofluorescence, cells were fixed in 2% paraformal-
dehyde in PBS and then permeabilized with Triton X-100. Slides
were blocked with 10% normal goat serum (NGS; Sigma,
G9023) and then incubated overnight at 4C with 1.25 mg/ml
rabbit polyclonal anti-LC3B (Abgent, AP1802a) in 10% NGS in
PBS or with 1 mg/ml mouse monoclonal antibody to ATPIF1
(ATPase inhibitory factor 1; Abcam, ab110277) in 10% NGS in
PBS. Bound antibody was visualized with Alexa Fluor 488-conju-
gated goat anti-rabbit IgG (Invitrogen, A11034) or with Alexa
Fluor 568-conjugated goat anti-mouse IgG (Invitrogen,
A11031). Cells were mounted in Vectashield with DAPI (Vector,
H-1500), and viewed using a Zeiss Axiovert S100 microscope
using OpenLab software (PerkinElmer, Cambridge, UK) or a
LSM 510 Meta Confocal microscope (Carl Zeiss, Cambridge,
UK) using LSM Meta 510 software (Carl Zeiss, Cambridge,
UK).
Cytokines
Cytokines in cell culture supernatants were measured by
ELISA using the following kits: Murine IL1B, (R&D systems,
DY401); murine TNF (eBioscience, 88–7324–22) and human
IL1B (eBioscience, 88–7010–22).
SiRNA and transfection
Control siRNA and siRNAs to the indicated genes were all
OnTarget plus SMART pool siRNA (Dharmacon, Thermo Sci-
entific, Loughborough, UK). pUNO1-mAtg5 was from Invivo-
gen (puno1-matg5). The tandem expression plasmid for LC3B
(pDest-mCherry-EGFP-LC3B) was kindly provided by Terje
Johansen (University of Tromsø, Norway).30 Silencing con-
structs were introduced into cells using HiPerfect transfection
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reagent (Qiagen, 301705). Transfection of BMDMs was opti-
mized using SiGLO Green transfection indicator (Dharmacon,
D-001630–01–05) and flow cytometry. We routinely achieved
transfection efficiencies greater than 90%. For efficient knock-
down, cells were cultured for 24 to 48 h.
Cytoplasmic mitochondrial DNA
For measuring cytoplasmic mtDNA, 1 £ 107 cells infected as
indicated were homogenized with a Dounce homogenizer in
100 mM NaOH solution, pH 7.4, containing 0.25 M sucrose
(Sigma, S0389), 1 mM EDTA, and protease inhibitors (Roche,
04693159001), then centrifuged at 800 g for 12 min at 4C.
The protein concentrations were determined with Micro BCA
protein detection kit (Pierce, 23235) and adjusted to equal con-
centrations across different samples, followed by centrifugation
at 12,000 g for 30 min at 4C for the production of a superna-
tant corresponding to the cytosolic fraction. Total DNA was iso-
lated from 200 ml of the cytosolic fraction with a DNeasy blood
and tissue kit (Qiagen, 69504). Quantitative PCR was used for
measurement of cytoplasmic mitochondrial DNA mtDNA using
SYBR Green PCR master mix (Applied Biosystems, 4385612).
The copy number of cytoplasmic mtDNA was normalized to
that of nuclear DNA as the ratio of DNA encoding MT-CO1
(mitochondrially encoded cytochrome c oxidase I) to nuclear
DNA encoding Rn18S rRNA.
The following primers were used for q-PCR:
Rn18S sense, 50-TAGAGGGACAAGTGGCGTTC-30,
anti-sense, 50-CGCTGAGCCAGTCAGTGT-30;
Mt-Co1 sense, 50-GCCCCAGATATAGCATTCCC-30,
anti-sense, 50-GTTCATCCTGTTCCTGCTCC-30.
The copy number of DNA encoding MT-CO1 was measured
by quantitative real-time PCR with same volume of the DNA
solution.
Isolation of mitochondrial DNA
Mouse mitochondrial DNA (mtDNA) was isolated from
40 £ 106 J774A.1cell with a mitochondrial DNA isolation kit
(Thermo scientific, 89874) according to the manufacturer’s
instructions. Mitochondrial DNA was isolated from the pellet
with a DNeasy blood and tissue kit (Qiagen, 69504). To gener-
ate oxidized mtDNA, the material was incubated with 100 mM
hydrogen peroxide for 30 min at 37C.
Transfection of mtDNA
BMDMs were transfected for 6 h with 2 mg/ml isolated
mtDNA or oxidized mtDNA through the use of 3 ml Attractene
(Qiagen, 301005) according to the manufacturer’s instructions.
Protein transfection
Protein transfection was performed using Polyplus reagent
(Polyplus, pplu50–01) for 5 h. After washing, cells were infected
with PA103DUDT for 4 h (MOI 1:25).
Cell culture and transient transfection
HEK293 cells were maintained in Dulbecco’s modified
Eagle’s medium (Gibco, 21969–035) supplemented with 10%
fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin. The expression vector pcDNA3 con-
taining DNA insert encoding either NLRC4, NAIP and CASP1
(125 ng/dish of each) were mixed with transfection reagent (Jet-
PEI; Polyplus, 101–01N) according to the manufacturer’s
instructions. After 48 h cells were transfected with mitochondrial
DNA using the designated transfection reagent and subsequently
stained for CASP1 using the FAM FLICA CASP1 assay (Immu-
nochemistry Technologies, 98).
Generation of mtDNA deficient r cells
J774A.1 macrophages were grown in RPMI 1640 media sup-
plemented as above but also with added uridine (25 mg/ml).
Ethidium bromide (500 ng/ml) was added to the medium for 15
d.28 Depletion of mitochondrial DNA was evaluated by quanti-
tative PCR for the mitochondrial gene mt-Co1, compared to
nuclear DNA encoding 18S rRNA, protein gel blot to detect
mitochondrial ATPIF1, and flow cytometry for measurement of
mitochondrial mass using MitoTracker Green FM stain (Invitro-
gen, M7514).
Flow cytometry
Mitochondrial ROS were measured in cells after infection as
indicated by using 2.5 mM for 30 min at 37C MitoSOX Red
staining (Invitrogen, M36008). For measurement of mitochon-
drial mass, cells were stained for 30 min at 37C with 50 nM
MitoTracker Green FM (Invitrogen, M7514). Intracellular
LC3B-II was detected following the method described.39 Cells
were analyzed using a CyAn ADP (Beckman Coulter, CY20030)
or FACScalibur flow cytometer (BD, Oxford, UK). Flow cytom-
etry data was analyzed with Flowjo Software (Tree Star Inc. Ash-
land, OR, USA).
Transmission electron microscopy
BMDM cells infected by PA for 4 h were harvested, washed
with Sorensen Phosphate buffer and prefixed with 2% glutaralde-
hyde, followed by post-fixation with 1% OsO4 in 6.6 mM
Sorensen’s phosphate buffer (0.133 M Na2HPO4, 0.133 M
KH2PO4, pH 7.2). All pellets were dehydrated stepwise in a
graded series of ethanol and embedded in araldite CY212. Ultra-
thin sections were double stained with uranyl acetate and lead cit-
rate (Agar Scientific, AGR1260A and AGR1210) and examined
using a Tecnai transmission electron microscope (Model No.
943205018411, FEI Company, Czech Republic) equipped with
Olympus Veleta digital camera (Olympus, Munster, Germany).
Immunoprecipitation
BMDMs were preloaded with BrdU (10 mM; Sigma, B5002)
for 48 h and then infected with PA103DUDT at MOI 25. After
infection cells were washed twice with ice-cold PBS and then
lysed in 500 ml RIPA lysis buffer (Thermo Scientific, 89900) for
30 min. Lysates were precleared by addition of 50 ml of anti-rab-
bit IgG beads (eBioscience, 00–8800–25) on ice for 50 min with
gentle agitation. Five mg of rabbit anti-NLRC4 (Novus biologi-
cal, NBP1–78979ss) antibody or 5 mg of negative control rabbit
IgG (Dakocytomation, X0936) were added to 250 ml aliquots of
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the lysate and incubated on ice for 1.5 h. Immune complexes
were collected using anti-rabbit IgG beads and washed 3 times
with ice-cold RIPA lysis buffer. Bound material was eluted with
distilled water at 100C for 10 min. A 20 ml aliquot was ana-
lyzed on a standard western blot for NLRC4 protein. DNA in
the remaining 80 ml aliquot was alkali denatured and neutralized
before transferring to nitrocellulose membranes. DNA was
detected with monoclonal antibodies to BrdU (1.5 mg/ml;
Sigma, B8434) or mouse anti-8OH-dG (0.5 mg/ml; Rockland
Immunochemicals, 200–301-A99) or anti-dsDNA (abcam,
27156) and enhanced chemiluminescence ECL.
Animal model
Female C57/BL6 mice aged 8 wk were obtained from Harlan
UK. Mice were randomly divided into to 6 groups (n D 3 per
group). Three control groups were injected intraperitoneally (ip)
with sterile PBS, rapamycin (1.5 g/kg), or 3-MA (Sigma,
M9281; 20mg/kg). Experimental groups were injected ip with
PA103DUDT (107 cfu) alone or with rapamycin or 3-MA as
above. Six h after infection, animals were sacrificed and blood
and peritoneal fluid collected for analysis as indicated.
Statistics
Comparison between groups at one time point was made with
an unpaired Student t test using Prism 6 (GraphPad Software
Inc. San Diego, CA, USA). A P value of < 0.05 was considered
significant.
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